Mangoceuticals (MGRX) Retained Earnings (2023 - 2025)
Historic Retained Earnings for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to -$37.9 million.
- Mangoceuticals' Retained Earnings fell 11059.7% to -$37.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.9 million, marking a year-over-year decrease of 11059.7%. This contributed to the annual value of -$20.8 million for FY2024, which is 8530.7% down from last year.
- Mangoceuticals' Retained Earnings amounted to -$37.9 million in Q3 2025, which was down 11059.7% from -$31.6 million recorded in Q2 2025.
- In the past 5 years, Mangoceuticals' Retained Earnings ranged from a high of -$6.9 million in Q2 2023 and a low of -$37.9 million during Q3 2025
- Its 3-year average for Retained Earnings is -$19.1 million, with a median of -$17.0 million in 2024.
- Over the last 5 years, Mangoceuticals' Retained Earnings had its largest YoY gain of 8530.7% in 2024, and its largest YoY loss of 13302.01% in 2024.
- Mangoceuticals' Retained Earnings (Quarter) stood at -$11.2 million in 2023, then tumbled by 85.31% to -$20.8 million in 2024, then tumbled by 82.05% to -$37.9 million in 2025.
- Its last three reported values are -$37.9 million in Q3 2025, -$31.6 million for Q2 2025, and -$25.9 million during Q1 2025.